Roberta Malaguarnera Selected Research

Roberta Malaguarnera Research Topics

Disease

27	Neoplasms (Cancer) 10/2023 - 03/2006
9	Thyroid Neoplasms (Thyroid Cancer) 11/2018 - 12/2005
7	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2014
4	Non-alcoholic Fatty Liver Disease 11/2021 - 01/2012
4	Insulin Resistance 10/2020 - 01/2011
4	Carcinogenesis 11/2018 - 01/2011
3	Diabetes Mellitus 07/2022 - 10/2020
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2017
2	Obesity 07/2022 - 08/2011
2	Fibrosis (Cirrhosis) 11/2021 - 08/2021
2	Hyperglycemia 08/2021 - 06/2021
2	Body Weight (Weight, Body) 08/2021 - 11/2013
2	Type 2 Diabetes Mellitus (MODY) 10/2020 - 08/2011
2	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 04/2014
2	Hyperinsulinism (Hyperinsulinemia) 01/2017 - 08/2011
2	Papillary Thyroid Cancer 03/2011 - 07/2007
1	Lactic Acidosis 07/2022
1	Albuminuria 07/2022
1	Diabetes Complications 07/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2022
1	Herpes Simplex 01/2022
1	Triple Negative Breast Neoplasms 11/2021
1	Infections 11/2021
1	COVID-19 11/2021
1	Autoimmune Hypophysitis 11/2021
1	Fatty Liver 08/2021
1	Hypercholesterolemia 08/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Idiopathic Pulmonary Fibrosis 11/2020
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 03/2015
1	Leiomyosarcoma 10/2014

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 10/2023 - 01/2011
12	Protein Isoforms (Isoforms)IBA 11/2021 - 12/2005
11	Insulin ReceptorIBA 11/2021 - 01/2011
8	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 03/2011
7	LigandsIBA 01/2019 - 08/2011
7	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018 - 01/2011
6	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2017 - 01/2011
5	Estrogens (Estrogen)FDA Link 12/2017 - 08/2012
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2008
4	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2020
3	Insulin-Like PeptidesIBA 01/2019 - 01/2017
3	Collagen ReceptorsIBA 01/2019 - 06/2015
3	IntegrinsIBA 01/2019 - 01/2017
3	Discoidin Domain Receptor 1IBA 01/2017 - 06/2015
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2014 - 06/2008
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2013 - 08/2011
2	PalmitatesIBA 07/2022 - 10/2020
2	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2021 - 11/2013
2	Glucagon (Glukagon)FDA Link 01/2021 - 10/2020
2	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2018 - 03/2011
2	CollagenIBA 01/2018 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 01/2017
2	AndrogensIBA 12/2017 - 04/2014
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017 - 01/2011
2	ThiazolidinedionesIBA 01/2017 - 11/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2016 - 06/2015
2	Oncogene Proteins (Oncogene Protein)IBA 10/2014 - 01/2011
2	Phosphotransferases (Kinase)IBA 10/2014 - 07/2007
2	Small Interfering RNA (siRNA)IBA 01/2008 - 03/2006
1	InterferonsIBA 11/2022
1	BiguanidesIBA 07/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	ChemokinesIBA 11/2021
1	Complement System Proteins (Complement)IBA 11/2021
1	Hormones (Hormone)IBA 11/2021
1	SteroidsIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	AntibodiesIBA 11/2021
1	Coffee FDA Link 08/2021
1	Long Noncoding RNAIBA 08/2021
1	ElementsIBA 01/2021
1	AntidotesIBA 01/2021
1	CopperIBA 12/2017
1	Trace Elements (Biometals)IBA 12/2017
1	MetalsIBA 12/2017
1	ZincIBA 12/2017
1	Heavy MetalsIBA 12/2017
1	IodineIBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	Coconut OilIBA 01/2017
1	lauric acid (dodecanoic acid)IBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	CateninsIBA 01/2017
1	TrabectedinIBA 03/2015
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 10/2014
1	Estrogen Receptor alphaIBA 10/2014
1	GTP-Binding Proteins (G-Protein)IBA 10/2014
1	Sirolimus (Rapamycin)FDA Link 10/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2014
1	Androgen Receptors (Androgen Receptor)IBA 04/2014
1	Androgen Antagonists (Antiandrogens)IBA 04/2014
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2013

Therapy/Procedure

14	Therapeutics 07/2022 - 07/2007
1	Drug Therapy (Chemotherapy) 01/2017